Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls.
Michelle C. Janelsins(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Tim A. Ahles(Memorial Sloan Kettering Cancer Center), Luke J. Peppone(University of Rochester Medical Center), Lori M. Minasian(National Cancer Institute), Supriya G. Mohile(University of Rochester Medical Center), Judith O. Hopkins(Novant Health), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Shaker R. Dakhil(Cancer Center of Kansas), Allison Magnuson(University of Rochester Medical Center), K Schmidt(Metro-Minnesota Community Oncology Research Consortium), Oxana Palesh(Virginia Commonwealth University), Ann M. O’Mara(National Cancer Institute), AnnaLynn M. Williams(University of Rochester)
Cited by 11
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670